網頁2024年11月30日 · Our data suggest that these genes might one of the roadblock for cancer cell reprogramming. Furthermore, we provide new insights into application of iPSCs technology in cancer cell field for therapeutic purposes. Affiliations 1 Department of Stem Cell Biology, Konkuk University School of Medicine, Seoul, Korea. ... 網頁2024年1月7日 · Background: High-dose chemotherapy with autologous stem cell rescue (HDCT) is a promising treatment for patients with stage III, HER2-negative, homologous recombination deficient (HRD) breast cancer. Clinical effectiveness and cost-effectiveness are currently under investigation in an international multicenter randomized controlled trial.
Targeting Cancer Stem Cells in Triple-Negative Breast Cancer
網頁9 小時前 · The FDA has requested positive results from a second clinical study of SGX301 in patients with early stage cutaneous T-cell lymphoma before filing a new drug application. … 網頁A stem cell transplant (also known as a bone marrow transplant) lets doctors give higher doses of chemotherapy, sometimes along with radiation therapy. The doses of chemotherapy drugs are normally limited by the side effects these drugs can cause. Higher doses can’t be used, even if they might kill more cancer cells, because they would ... how many counts is a minim worth
High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Combination Chemotherapy …
網頁2024年11月19日 · Breast cancer stem cells (CSCs) or tumor-initiating cells are thought to play an important role in tumor development, therapy resistance, and progression of triple-negative breast cancer (TNBC). To overcome the poor prognosis of TNBC, novel therapies targeting CSCs need to be developed. 網頁2024年6月9日 · Triple-negative breast cancer (TNBC), a specific subtype of breast cancer that does not express estrogen receptor (ER), progesterone receptor (PR), or human epidermal growth factor receptor 2 (HER-2), has clinical features that include high invasiveness, high metastatic potential, proneness to relapse, and poor prognosis. … 網頁2024年3月9日 · In this context, a small subpopulation of highly tumourigenic cancer cells within the tumour bulk, commonly designated as breast cancer stem cells (BCSCs), have been suggested as key elements in therapy resistance, which are responsible for breast cancer relapses and distant metastasis. how many counts is a shot